Modified solid-phase alloantibody detection for improved crossmatch prediction

Human Immunology

Volumn 74, Issue 1, 2013, Pages 32-40

  Wahrmann, Markus ^a   Hlavin, Gerald ^a   Fischer, Gottfried ^a   Marinova, Lena ^a   Schwaiger, Elisabeth ^a   Hörl, Walter H ^a   Zlabinger, Gerhard J ^b   Körmöczi, Günther F ^a   König, Franz ^a   Böhmig, Georg A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D; DITHIOTHREITOL; DONOR SPECIFIC ANTIBODY; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE; BLOOD GROUP TYPING; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT FIXATION; CONTROLLED STUDY; HUMAN; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE ANTIGEN BEAD ASSAY; SOLID; T LYMPHOCYTE;

B-LYMPHOCYTES; COMPLEMENT C4B; CYTOTOXICITY TESTS, IMMUNOLOGIC; DITHIOTHREITOL; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; ORGAN TRANSPLANTATION; PEPTIDE FRAGMENTS; ROC CURVE; T-LYMPHOCYTES; TISSUE DONORS;

EID: 84870878266     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.012     Document Type: Article

References (37)

1. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969, 280:735-739.
2. Cecka J.M., Zhang Q., Reed E.F. Preformed cytotoxic antibodies in potential allograft recipients: recent data. Hum Immunol 2005, 66:343-349.
3. Pei R., Wang G., Tarsitani C., Rojo S., Chen T., Takemura S., et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998, 59:313-322.
4. Pei R., Lee J.H., Shih N.J., Chen M., Terasaki P.I. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003, 75:43-49.
5. Vaidya S., Partlow D., Susskind B., Noor M., Barnes T., Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead Luminex assay. Transplantation 2006, 82:1524-1528.
6. Zachary A.A., Sholander J.T., Houp J.A., Leffell M.S. Using real data for a virtual crossmatch. Hum Immunol 2009, 70:574-579.
7. Amico P., Honger G., Steiger J., Schaub S. Utility of the virtual crossmatch in solid organ transplantation. Curr Opin Organ Transplant 2009, 14:656-661.
8. Tait B.D., Hudson F., Cantwell L., Brewin G., Holdsworth R., Bennett G., et al. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) 2009, 14:247-254.
9. Ferrari P., Fidler S., Wright J., Woodroffe C., Slater P., Van Althuis-Jones A., et al. Virtual crossmatch approach to maximize matching in paired kidney donation. Am J Transplant 2010, 11:272-278.
10. Gupta A., Iveson V., Varagunam M., Bodger S., Sinnott P., Thuraisingham R.C. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?. Transplantation 2008, 85:1200-1204.
11. Lefaucheur C., Suberbielle-Boissel C., Hill G.S., Nochy D., Andrade J., Antoine C., et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008, 8:324-331.
12. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., van Heurn L.W., Claas F.H., van Hooff J.P., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008, 85:1086-1090.
13. Amico P., Hönger G., Mayr M., Steiger J., Hopfer H., Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009, 87:1681-1688.
14. Wahrmann M., Bartel G., Exner M., Regele H., Körmöczi G.F., Fischer G.F., et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009, 22:982-989.
15. Süsal C., Ovens J., Mahmoud K., Dohler B., Scherer S., Ruhenstroth A., et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a collaborative transplant study report. Transplantation 2011, 91:883-887.
16. Schnaidt M., Weinstock C., Jurisic M., Schmid-Horch B., Ender A., Wernet D. HLA antibody specification using single-antigen beads - a technical solution for the prozone effect. Transplantation 2011, 92:510-515.
17. Wahrmann M., Exner M., Regele H., Derfler K., Körmöczi G.F., Lhotta K., et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 2003, 275:149-160.
18. Wahrmann M., Exner M., Haidbauer B., Schillinger M., Regele H., Körmöczi G., et al. [C4d]FlowPRA screening - a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Hum Immunol 2005, 66:526-534.
19. Wahrmann M., Exner M., Schillinger M., Haidbauer B., Regele H., Körmöczi G.F., et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006, 6:1033-1041.
20. Smith J.D., Hamour I.M., Banner N.R., Rose M.L. C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007, 7:2809-2815.
21. Bartel G., Wahrmann M., Exner M., Regele H., Huttary N., Schillinger M., et al. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008, 8:41-49.
22. Böhmig G.A., Bartel G., Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr Opin Organ Transplant 2008, 13:411-418.
23. Chen G., Sequeira F., Tyan D.B. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011, 72:849-858.
24. Le Bas-Bernardet S., Hourmant M., Valentin N., Paitier C., Giral-Classe M., Curry S., et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 2003, 75:477-482.
25. Eng H.S., Bennett G., Bardy P., Coghlan P., Russ G.R., Coates P.T. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools. Hum Immunol 2009, 70:595-599.
26. El-Awar N., Terasaki P.I., Nguyen A., Sasaki N., Morales-Buenrostro L.E., Saji H., et al. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009, 70:844-853.
27. Cai J., Terasaki P.I., Anderson N., Lachmann N., Schonemann C. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009, 88:226-230.
28. Pereira S., Perkins S., Lee J.H., Shumway W., LeFor W., Lopez-Cepero M., et al. Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?. Hum Immunol 2011, 72:492-498.
29. *02:01: a case report. Hum Immunol 2011, 72:1045-1048.
30. Yabu J.M., Higgins J.P., Chen G., Sequeira F., Busque S., Tyan D.B. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011, 91:342-347.
31. Sutherland S.M., Chen G., Sequeira F.A., Lou C.D., Alexander S.R., Tyan D.B. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2012, 16:12-17.
32. Zou Y., Stastny P. Role of MICA in the immune response to transplants. Tissue Antigens 2010, 76:171-176.
33. Kosmoliaptsis V., Bradley J.A., Peacock S., Chaudhry A.N., Taylor C.J. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation 2009, 87:813-820.
34. Bartel G., Wahrmann M., Exner M., Regele H., Schillinger M., Hörl W.H., et al. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007, 83:727-733.
35. Claas F.H., Rahmel A., Doxiadis I.I. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009, 88:447-452.
36. Nikaein A., Cherikh W., Nelson K., Baker T., Leffell S., Bow L., et al. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Transplantation 2009, 87:557-562.
37. Cecka J.M., Kucheryavaya A.Y., Reinsmoen N.L., Leffell M.S. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am J Transplant 2011, 11:719-724.